trial

EPI-MINN: Targeting Cognition and Motivation

NCTId NCT05112432
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Active Not Recruiting
Enrollment 400 (estimated)
Sponsored by University of Minnesota
Primary completion 2026-07-31
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Active Not Recruiting
Enrollment
400 (estimated)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Single
Start
2021-08-12
Primary completion
2026-07-31
Eligibility
ALL · 15 Years · 40 Years

Interventions & indications

Drugs
Cognitive and Social Cognitive TrainingPersonalized Real-Time Intervention for Motivational Enhancement (PRIME) AppEarly Psychosis Coordinated Specialty Care

Sponsors

University of MinnesotaLead Sponsor
National Institute of Mental Health (NIMH)Collaborator

Investigators

1
Sophia Vinogradov, MDPrincipal Investigator

Sites

3 total
Duluth, United StatesMinneapolis, United StatesMinneapolis, United States

Facts & assertions

4 sourced
Enrollment
400
Phase
NA
Primary Completion Date
2026-07-31
Status
ACTIVE_NOT_RECRUITING
relationships
The graph out of here
drug
Cognitive and Social Cognitive Training
drug
Personalized Real-Time Intervention for Motivational Enhancement (PRIME) App
drug
Early Psychosis Coordinated Specialty Care
drug
lead_sponsor
University of Minnesota
company
collaborator
National Institute of Mental Health (NIMH)
company
indication
Psychosis
indication
Psychotic Disorders
indication
investigator
Sophia Vinogradov, MD
person